REVIEW 14 cited by
DrugAgent: Automating AI-aided Drug Discovery Programming through LLM Multi-Agent Collaboration
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
DrugAgent: Automating AI-aided Drug Discovery Programming through LLM Multi-Agent Collaboration
read the original abstract
Recent progress in Large Language Models (LLMs) has drawn attention to their potential for accelerating drug discovery. However, a central problem remains: translating theoretical ideas into robust implementations in the highly specialized context of pharmaceutical research. This limitation prevents practitioners from making full use of the latest AI developments in drug discovery. To address this challenge, we introduce DrugAgent, a multi-agent framework that automates machine learning (ML) programming for drug discovery tasks. DrugAgent employs an LLM Planner that formulates high-level ideas and an LLM Instructor that identifies and integrates domain knowledge when implementing those ideas. We present case studies on three representative drug discovery tasks. Our results show that DrugAgent consistently outperforms leading baselines, including a relative improvement of 4.92% in ROC-AUC compared to ReAct for drug-target interaction (DTI). DrugAgent is publicly available at https://anonymous.4open.science/r/drugagent-5C42/.
Forward citations
Cited by 14 Pith papers
-
Scalable Agentic Reasoning for Designing Biologics Targeting Intrinsically Disordered Proteins
StructBioReasoner is a scalable multi-agent system that designs IDP-targeting biologics, with over 50% of 787 candidates for Der f 21 showing better binding free energy than human-designed references.
-
Inside the Unfair Judge: A Mechanistic Interpretability Account of LLM-as-Judge Bias
LLM-as-judge scoring biases concentrate in low-dimensional, type-specific activation subspaces that support bidirectional causal steering and cross-domain failure prediction.
-
Studying quantization trade-offs for efficient inference deployment in machine translation
Quantized Hy-MT2 models stay accurate at long context, but quantized EuroLLM 9B/22B models collapse (up to ~60% chrF++ drop) while W4A8/W8A8 plus 200–400-token chunking improves serving throughput.
-
Studying quantization trade-offs for efficient inference deployment in machine translation
Combining 200-400 token document chunking with W4A8/W8A8 quantization improves MT serving efficiency, while long-context translation quality collapses for quantized EuroLLM but not for quantized Hy-MT2.
-
A Precedent-Guided Co-Scientist for Side-Effect-Aware Drug Redesign
PRECEDE redesigns parent drugs to mitigate a specified side effect by classifying liability mechanism, transferring strategies from historical precedents, and ranking candidates with in silico proxies under human checkpoints.
-
Closed-loop Auto Research for Molecular Property Prediction: Discovering and Certifying Generalizable Improvements
Closed-loop LM-agent auto research finds some transferable gains on molecular property prediction benchmarks via external data but shows non-transfer for model and feature edits selected on validation.
-
Large Language Models Meet Biomedical Knowledge Graphs for Mechanistically Grounded Therapeutic Prioritization
DrugKLM integrates knowledge graphs and LLMs to prioritize mechanistically plausible drug repurposing candidates, outperforming baselines and aligning scores with improved survival signatures in cancer data.
-
MolClaw: An Autonomous Agent with Hierarchical Skills for Drug Molecule Evaluation, Screening, and Optimization
MolClaw deploys a hierarchical skill system (tool, workflow, and discipline levels) to achieve state-of-the-art results on MolBench tasks requiring 8 to 50+ sequential tool calls in drug discovery.
-
IR-Agent: Expert-Inspired LLM Agents for Structure Elucidation from Infrared Spectra
IR-Agent is a multi-agent LLM framework that emulates expert IR spectral analysis procedures to improve molecular structure elucidation accuracy and adaptability.
-
GenoMAS: A Multi-Agent Framework for Scientific Discovery via Code-Driven Gene Expression Analysis
GenoMAS deploys six specialized LLM agents with guided planning to preprocess transcriptomic data and identify genes, reaching 89.13% composite similarity and 60.48% F1 on the GenoTEX benchmark while outperforming pri...
-
Evaluating Agentic Bioinformatics through Function, Evidence, and Validation
Agentic bioinformatics systems mostly demonstrate planning and tool execution but rarely prospective empirical validation, so the paper argues evaluation should center on inspectable workflow trajectories (FEV) rather...
-
MolClaw: An Autonomous Agent with Hierarchical Skills for Drug Molecule Evaluation, Screening, and Optimization
MolClaw deploys a hierarchical skill architecture to reach state-of-the-art results on a new benchmark of multi-step drug discovery tasks.
-
DrugPlayGround: Benchmarking Large Language Models and Embeddings for Drug Discovery
DrugPlayGround is a new benchmark framework for evaluating LLMs on text-based descriptions of physiochemical drug characteristics, synergism, drug-protein interactions, and physiological responses.
-
Valid Property-Enhanced Contrastive Learning for Targeted Optimization & Resampling for Novel Drug Design
VECTOR+ combines contrastive learning and Gaussian mixture sampling to generate novel, synthetically plausible inhibitors from low-data datasets, with improved docking scores over known compounds.
discussion (0)
Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.